Grown Rogue International (GRUSF) EPS (Diluted) Growth (1y) (2010 - 2026)
Grown Rogue International (GRUSF) EPS (Diluted) Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | -304.28% |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 1.28% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -15.70% |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 13.47% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 30.20% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 385.28% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Grown Rogue International | 110.47 Mn | 98.93 Mn | 5.37 Mn | -190.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -190.54% |
| Sep 30, 2025 | 418,584,644.23% |
| Jan 31, 2023 | 276.17% |
| Jan 31, 2022 | 98.47% |
| Jul 31, 2021 | 93.17% |
| Apr 30, 2021 | 11.13% |
| Jan 31, 2021 | 33.08% |
| Oct 31, 2020 | 101.26% |
| Jul 31, 2020 | -4.24% |
| Apr 30, 2020 | 21.79% |
| Jan 31, 2020 | 66.47% |
| Oct 31, 2019 | 16.90% |
| Jul 31, 2019 | 73.56% |
| Apr 30, 2019 | -41.57% |
| Jan 31, 2019 | -270.50% |
| Aug 31, 2018 | 103.77% |
| May 31, 2018 | 240,113,177.84% |
| Feb 28, 2018 | -19,402,215,876.22% |
| Nov 30, 2017 | 7,916,994,518.13% |
| Aug 31, 2017 | -288,235.78% |